402 results on '"Finetti, Pascal"'
Search Results
2. Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer
3. Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
4. The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
5. Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
6. The MonarchE trial: improving the clinical outcome in HR+/HER2− early breast cancer: recent results and next steps
7. ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
8. An OMA1 redox site controls mitochondrial homeostasis, sarcoma growth, and immunogenicity
9. Supplementary Data from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
10. Supplementary Tables 1-7 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
11. Data from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
12. Data from “Wnt/β-Catenin in GIST”—Letter
13. Supplementary Table from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
14. Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
15. Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
16. Supplementary Figure from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
17. Supplementary Data from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
18. Data from “Wnt/β-Catenin in GIST”—Letter
19. Supplementary Figures 1-4 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
20. Supplementary Table from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
21. Supplementary Tables 1-7 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
22. Figure S1 from “Wnt/β-Catenin in GIST”—Letter
23. Supplementary Table from Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
24. Figure S1 from “Wnt/β-Catenin in GIST”—Letter
25. Data from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
26. Supplementary Figures 1-4 from Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer
27. RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
28. Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers
29. Supplementary Tables S1-S5 from Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers
30. Supplementary Table 2 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
31. Supplementary Tables from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
32. Supplementary Tables from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
33. Supplementary Tables from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
34. Supplementary Data File and Legend from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
35. Supplementary Table 1 from Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)
36. Supplementary Table 3 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
37. Supporting Information from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
38. Supplementary Figure 7 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
39. Supplementary Tables from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
40. Supplementary Data File and Legend from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
41. Supplementary Figure S1 from Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers
42. Supplementary Materials and Methods from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
43. Supplementary Figures from Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
44. Supplementary Figure 1 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
45. Supplementary Figure 5 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
46. Supplementary Figure 3 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
47. Supplementary Figure 6 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
48. Supplementary Figure Legend from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
49. Supplementary Figures from Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
50. Supplementary Table 1 from Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.